News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
817,090 Results
Type
Article (66140)
Company Profile (707)
Press Release (750219)
Multimedia
Podcasts (174)
Webinars (30)
Section
Business (223540)
Career Advice (3202)
Deals (38431)
Drug Delivery (158)
Drug Development (88507)
Employer Resources (191)
FDA (18033)
Job Trends (16599)
News (380586)
Policy (37675)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3024)
Academic (1)
Accelerated approval (45)
Adcomms (37)
Allergies (174)
Alliances (55328)
ALS (206)
Alzheimer's disease (1884)
Antibody-drug conjugate (ADC) (413)
Approvals (18269)
Artificial intelligence (676)
Autoimmune disease (247)
Automation (53)
Bankruptcy (396)
Best Places to Work (12532)
BIOSECURE Act (22)
Biosimilars (219)
Biotechnology (439)
Bladder cancer (185)
Brain cancer (71)
Breast cancer (724)
Cancer (5622)
Cardiovascular disease (494)
Career advice (2726)
Career pathing (46)
CAR-T (329)
CDC (70)
Celiac Disease (2)
Cell therapy (881)
Cervical cancer (43)
Clinical research (75446)
Collaboration (2072)
Company closure (6)
Compensation (1289)
Complete response letters (90)
COVID-19 (3008)
CRISPR (110)
C-suite (1051)
Cystic fibrosis (159)
Data (7245)
Decentralized trials (3)
Denatured (58)
Depression (175)
Dermatology (59)
Diabetes (590)
Diagnostics (7362)
Digital health (54)
Diversity (13)
Diversity, equity & inclusion (47)
Drug discovery (327)
Drug pricing (237)
Drug shortages (36)
Duchenne muscular dystrophy (286)
Earnings (96638)
Editorial (69)
Employer branding (24)
Employer resources (169)
Events (130032)
Executive appointments (1107)
FDA (21587)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1724)
Gene editing (236)
Generative AI (60)
Gene therapy (736)
GLP-1 (1190)
Government (5367)
Grass and pollen (8)
Guidances (400)
Healthcare (20846)
HIV (80)
Huntington's disease (58)
IgA nephropathy (96)
Immunology and inflammation (318)
Immuno-oncology (92)
Indications (158)
Infectious disease (3352)
Inflammatory bowel disease (223)
Inflation Reduction Act (17)
Influenza (138)
Intellectual property (284)
Interviews (589)
IPO (17597)
IRA (60)
Job creations (4448)
Job search strategy (2231)
JPM (71)
Kidney cancer (19)
Labor market (95)
Layoffs (646)
Leadership (45)
Legal (9361)
Liver cancer (106)
Longevity (29)
Lung cancer (756)
Lymphoma (417)
Machine learning (54)
Management (64)
Manufacturing (995)
MASH (193)
Medical device (15020)
Medtech (15102)
Mergers & acquisitions (22006)
Metabolic disorders (1577)
mRNA (212)
Multiple sclerosis (182)
NASH (23)
Neurodegenerative disease (434)
Neuropsychiatric disorders (115)
Neuroscience (3402)
Neurotech (1)
NextGen: Class of 2026 (7530)
Non-profit (5112)
Now hiring (74)
Obesity (770)
Opinion (351)
Ovarian cancer (189)
Pain (247)
Pancreatic cancer (267)
Parkinson's disease (365)
Partnered (36)
Patents (581)
Patient recruitment (620)
Peanut (65)
People (64703)
Pharmaceutical (125)
Pharmacy benefit managers (36)
Phase 1 (23442)
Phase 2 (32982)
Phase 3 (24797)
Pipeline (7318)
Policy (363)
Postmarket research (3012)
Preclinical (10313)
Press Release (72)
Prostate cancer (291)
Psychedelics (57)
Radiopharmaceuticals (328)
Rare diseases (1109)
Real estate (6916)
Recruiting (79)
Regulatory (28254)
Reports (58)
Research institute (2734)
Resumes & cover letters (506)
Rett syndrome (33)
RNA editing (21)
RSV (95)
Schizophrenia (177)
Series A (290)
Series B (214)
Service/supplier (28)
Sickle cell disease (115)
Special edition (29)
Spinal muscular atrophy (180)
Sponsored (52)
Startups (4108)
State (2)
Stomach cancer (21)
Supply chain (127)
Tariffs (100)
The Weekly (113)
Vaccines (1220)
Venture capital (108)
Weight loss (522)
Women's health (114)
Worklife (23)
Date
Last 7 days (672)
Last 30 days (2587)
Last 365 days (31845)
2026 (8500)
2025 (32176)
2024 (37650)
2023 (42399)
2022 (53747)
2021 (58498)
2020 (57431)
2019 (50976)
2018 (38760)
2017 (35759)
2016 (36017)
2015 (42009)
2014 (36186)
2013 (32036)
2012 (34333)
2011 (34577)
2010 (32901)
Location
Africa (1033)
Alabama (99)
Alaska (7)
Arizona (366)
Arkansas (15)
Asia (47174)
Australia (8057)
California (12729)
Canada (3591)
China (1328)
Colorado (544)
Connecticut (549)
Delaware (381)
Europe (107095)
Florida (1881)
Georgia (418)
Hawaii (4)
Idaho (68)
Illinois (1050)
India (87)
Indiana (595)
Iowa (24)
Japan (503)
Kansas (138)
Kentucky (50)
Louisiana (43)
Maine (85)
Maryland (1558)
Massachusetts (9297)
Michigan (379)
Minnesota (715)
Mississippi (7)
Missouri (154)
Montana (37)
Nebraska (29)
Nevada (142)
New Hampshire (89)
New Jersey (3387)
New Mexico (32)
New York (3363)
North Carolina (1731)
North Dakota (10)
Northern California (6219)
Ohio (393)
Oklahoma (25)
Oregon (52)
Pennsylvania (2547)
Puerto Rico (27)
Rhode Island (53)
South America (1428)
South Carolina (78)
South Dakota (1)
Southern California (4963)
Tennessee (204)
Texas (2025)
United States (45624)
Utah (383)
Vermont (1)
Virginia (324)
Washington D.C. (88)
Washington State (1046)
West Virginia (4)
Wisconsin (142)
Wyoming (2)
817,090 Results for "pro dex inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Exousia Pro, Inc. Announces Strategic Elimination of Future Dilutive Issuance of 47 Million Shares, Progresses Toward Definitive Agreements for Telehealth Acquisitions
March 5, 2026
·
4 min read
Business
Pro-Dex, Inc. Announces Fiscal 2024 First Quarter Results
PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2024 first quarter ended September 30, 2023.
November 2, 2023
·
6 min read
Press Releases
Exousia Pro, Inc. Accelerates Strategic Expansion with Third Telehealth Acquisition; Strengthens Pathway to Low-Cost Customer Acquisition
February 11, 2026
·
3 min read
Press Releases
Incision-Free, MRI-Guided Prostate Treatment with Profound’s TULSA-PRO® to be Featured in Multiple Presentations at the Upcoming 2026 Society of Interventional Radiology Scientific Meeting
April 1, 2026
·
7 min read
Job Trends
The Right Fit: Contract Work Finds Increasing Favor Among Employers, Professionals
Contract work opportunities have grown year over year, and recent reports show more people are in this type of role, according to
BioSpace
data. Three biopharma professionals share why they’ve become contractors and discuss the pros and cons.
February 26, 2026
·
6 min read
·
Angela Gabriel
Business
Pro-Dex, Inc. Announces Fiscal 2023 Third Quarter and Nine-Month Results
PRO-DEX, INC. announced financial results for its fiscal 2023 third quarter ended March 31, 2023.
May 4, 2023
·
8 min read
Press Releases
Pro-Dex, Inc. Announces Fiscal 2024 Fourth Quarter and Full-Year Results
September 6, 2024
·
9 min read
Press Releases
Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results
March 12, 2026
·
18 min read
Press Releases
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
December 3, 2025
·
4 min read
Press Releases
Bracco and ACIST Medical Systems Announce European Launch of ACIST Pro™ Diagnostic System
February 12, 2026
·
4 min read
1 of 81,709
Next
